Home > Waters & Kraus, LLP > Legal Library

Legal Articles: Waters & Kraus, LLP

 







Document(s) published by this organization: 53


View Page: 1  2  3  4  5  6  Next  
Show: results per page
Sort by:

HTMLMesothelioma Growth May Be Slowed by Aspirin
Waters Kraus LLP;
Legal Alert/Article
July 28, 2015, previously published on July 20, 2015
Aspirin may slow growth of mesothelioma, according to researchers at the University of Hawaii Cancer Center. Aspirin apparently prevents the harmful effects of High-Mobility Group Box 1 (HMGB1), an inflammatory molecule that aids mesothelioma in its growth and progression.

 

HTMLMultidistrict Litigation for Power Morcellator Lawsuits
Waters Kraus LLP;
Legal Alert/Article
July 28, 2015, previously published on July 17, 2015
Around the country, many women have been injured by power morcellators. These are medical devices that can spread undetected uterine cancers throughout the body during surgical procedures such as hysterectomies and myomectomies, in which fibroid uterine tumors are removed. Many lawsuits have...

 

HTMLArkansas Surgeon Monitoring Stryker Metal Hips
Waters Kraus LLP;
Legal Alert/Article
July 16, 2015, previously published on July 15, 2015
Arkansas orthopedic surgeon, Dr. Win Moore III, was shocked when he received a one-page letter from Stryker Corp. in 2012 announcing a problem with its metal-on-metal hip replacement systems. With more than 20 years of experience, the surgeon at Baxter Regional Bone and Joint Clinic, has performed...

 

HTMLSetting Priorities for Mesothelioma Research
Waters Kraus LLP;
Legal Alert/Article
July 15, 2015, previously published on July 13, 2015
Mesothelioma is a continuing problem around the world just as it is in the United States. Asbestos was completely banned in the United Kingdom more than 15 years ago (something that still has not happened in America). Even so, the UK saw 2,535 new mesothelioma cases in 2012, an annual number that...

 

HTMLNew Study Suggests Xarelto May Double Risk of Gastrointestinal Bleeding
Waters Kraus LLP;
White Paper
July 14, 2015, previously published on July 10, 2015
The British Medical Journal has recently published results from a new study indicating that Xarelto, as compared to the generic version of warfarin, may double the risk for gastrointestinal bleeding.

 

HTMLCalifornia Mesothelioma Doctors Studying Cryoablation
Shawna Forbes-King, Michael B. Gurien; Waters, Kraus & Paul;
Legal Alert/Article
July 14, 2015, previously published on July 6, 2015
Mesothelioma specialists at the Pacific Mesothelioma Center (PMC), David Geffen School of Medicine UCLA, have long been advocates for using cryoablation to treat mesothelioma tumors that return following surgery. Now PMC researchers reportedly are looking for ways to boost the effectiveness of...

 

HTMLIllinois Town to Abandon Benzene-Contaminated Government Building
Waters Kraus LLP;
Legal Alert/Article
July 13, 2015, previously published on July 8, 2015
The village of Roxana, Illinois is getting a new garage to house its street department workers and equipment. The current building reportedly sits atop an enormous plume of underground benzene.

 

HTML'Groundbreaking' Cure For Mesothelioma Uses Nanotechnology
Waters Kraus LLP;
Legal Alert/Article
July 7, 2015, previously published on June 30, 2015
June 30, 2015 - A medical school professor in Australia has teamed up with other scientists to develop a new mesothelioma treatment that reportedly has saved one patient’s life. Dr Glen Reid, an associate professor at the University of Sydney Medical School hopes his...

 

HTMLF.B.I. Investigates Power Morcellator Injuries
Waters Kraus LLP;
Legal Alert/Article
June 25, 2015, previously published on June 22, 2015
June 22, 2015 - The Federal Bureau of Investigation (F.B.I.) reportedly has launched an investigation into whether laws were broken by medical device manufacturers of the power morcellator device. Used in gynecologic surgery to perform hysterectomies and remove fibroid tumors, the power morcellator...

 

HTMLStandard Chemotherapy Regimen for Pleural Mesothelioma May Add Bevacizumab
Peter A. Kraus, Troyce G. Wolf; Waters & Kraus, LLP;
Legal Alert/Article
June 24, 2015, previously published on June 17, 2015
Malignant pleural mesothelioma may soon be getting a new standard of care. Bevacizumab may be added to the current standard chemotherapy regimen of pemetrexed and cisplatin. According to Dr. Gerald Zalcman, who recently presented a paper at the 2015 American Society of Clinical Oncology (ASCO)...

 


View Page: 1  2  3  4  5  6  Next